StreetInsider.com News Articles

Form 4 Lyell Immunopharma, Inc. For: Jul 16 Filed by: Innovative Cellular Therapeutics Holdings Ltd

Fri, 17 Jul 2026 21:45:00 -0400

si-local-file:///var/storage/secattach/20260717/26785533.html

Form 4 Lyell Immunopharma, Inc. For: Jul 16 Filed by: Innovative Cellular Therapeutics Holdings Ltd

Fri, 17 Jul 2026 21:45:00 -0400

si-local-file:///var/storage/secattach/20260717/26785533.html

Form S-3 Lyell Immunopharma, Inc.

Mon, 13 Jul 2026 17:15:00 -0400

si-local-file:///var/storage/secattach/20260713/26763216.html

Form S-3 Lyell Immunopharma, Inc.

Mon, 13 Jul 2026 17:15:00 -0400

si-local-file:///var/storage/secattach/20260713/26763216.html

Form 4 Lyell Immunopharma, Inc. For: Jun 29 Filed by: Innovative Cellular Therapeutics Holdings Ltd

Wed, 01 Jul 2026 12:37:00 -0400

si-local-file:///var/storage/secattach/20260701/26719250.html

Form 4 Lyell Immunopharma, Inc. For: Jun 29 Filed by: Innovative Cellular Therapeutics Holdings Ltd

Wed, 01 Jul 2026 12:37:00 -0400

si-local-file:///var/storage/secattach/20260701/26719250.html

Lyell Immunopharma (LYEL) Reiterated at Market Outperform by Citizens

Wed, 01 Jul 2026 04:52:30 -0400

Citizens analyst Reni Benjamin reiterated a Market Outperform rating and $34.00 price target on Lyell Immunopharma (NASDAQ: LYEL).

The analyst commented, "Lyell’s GCC x CD19 CAR-T cell therapy LYL273 remains in dose escalation in mCRC, with preliminary DL1/DL2 data already showing encouraging activity, including up to 67% ORR and mPFS of 7.8 months at DL2. The upcoming 2H26 efficacy update should include additional DL1/DL2 patients, longer follow-up from earlier cohorts, and the first look at DL3, providing a clearer view of whether higher dosing can improve response depth and durability while maintaining a manageable safety profile. Management has not guided to

Lyell Immunopharma Announces Participation in H.C. Wainwright 4th Annual Cell Therapy Virtual Conference

Thu, 25 Jun 2026 08:00:00 -0400

SOUTH SAN FRANCISCO, Calif., June 25, 2026 (GLOBE NEWSWIRE) -- Lyell Immunopharma, Inc. (Nasdaq: LYEL), a late-stage clinical company advancing a pipeline of next-generation chimeric antigen receptor (CAR) T-cell therapies for patients with cancer, today announced that members of its senior management team will participate in a fireside chat at the H.C. Wainwright 4^th Annual Cell Therapy Virtual Conference on Tuesday, June 30, 2026, at 1:30 pm Eastern Time.

A live webcast of the fireside chat and subsequent replay can be accessed through the Investors section of the Company’s website at www.lyell.com.

About

Lyell Immunopharma Announces Participation in H.C. Wainwright 4th Annual Cell Therapy Virtual Conference

Thu, 25 Jun 2026 08:00:00 -0400

SOUTH SAN FRANCISCO, Calif., June 25, 2026 (GLOBE NEWSWIRE) -- Lyell Immunopharma, Inc. (Nasdaq: LYEL), a late-stage clinical company advancing a pipeline of next-generation chimeric antigen receptor (CAR) T-cell therapies for patients with cancer, today announced that members of its senior management team will participate in a fireside chat at the H.C. Wainwright 4^th Annual Cell Therapy Virtual Conference on Tuesday, June 30, 2026, at 1:30 pm Eastern Time.

A live webcast of the fireside chat and subsequent replay can be accessed through the Investors section of the Company’s website at www.lyell.com.

About

Form 4 Lyell Immunopharma, Inc. For: Jun 15 Filed by: Innovative Cellular Therapeutics Holdings Ltd

Thu, 18 Jun 2026 21:59:00 -0400
si-local-file:///var/storage/secattach/20260618/26667756.html

Form 4 Lyell Immunopharma, Inc. For: Jun 15 Filed by: Innovative Cellular Therapeutics Holdings Ltd

Thu, 18 Jun 2026 21:59:00 -0400
si-local-file:///var/storage/secattach/20260618/26667756.html

Form SCHEDULE 13G/A Lyell Immunopharma, Inc. Filed by: Innovative Cellular Therapeutics Holdings Ltd

Thu, 18 Jun 2026 16:32:00 -0400
si-local-file:///var/storage/secattach/20260618/26666638.html

Form SCHEDULE 13G/A Lyell Immunopharma, Inc. Filed by: Innovative Cellular Therapeutics Holdings Ltd

Thu, 18 Jun 2026 16:32:00 -0400
si-local-file:///var/storage/secattach/20260618/26666638.html

Form 3 Lyell Immunopharma, Inc. For: May 18 Filed by: Innovative Cellular Therapeutics Holdings Ltd

Thu, 18 Jun 2026 16:06:00 -0400
si-local-file:///var/storage/secattach/20260618/26665975.html

Form 3 Lyell Immunopharma, Inc. For: May 18 Filed by: Innovative Cellular Therapeutics Holdings Ltd

Thu, 18 Jun 2026 16:06:00 -0400
si-local-file:///var/storage/secattach/20260618/26665975.html

Form 4 Lyell Immunopharma, Inc. For: May 11 Filed by: Seely Lynn

Mon, 15 Jun 2026 18:37:00 -0400
si-local-file:///var/storage/secattach/20260615/26648924.html

Form 4 Lyell Immunopharma, Inc. For: May 11 Filed by: Seely Lynn

Mon, 15 Jun 2026 18:37:00 -0400
si-local-file:///var/storage/secattach/20260615/26648924.html

Form 4 Lyell Immunopharma, Inc. For: May 11 Filed by: Lee Gary K.

Mon, 15 Jun 2026 18:35:00 -0400
si-local-file:///var/storage/secattach/20260615/26648922.html

Form 4 Lyell Immunopharma, Inc. For: May 11 Filed by: Lee Gary K.

Mon, 15 Jun 2026 18:35:00 -0400
si-local-file:///var/storage/secattach/20260615/26648922.html

Form 4 Lyell Immunopharma, Inc. For: May 11 Filed by: Hill Stephen J.

Mon, 15 Jun 2026 18:34:00 -0400
si-local-file:///var/storage/secattach/20260615/26648921.html

Form 4 Lyell Immunopharma, Inc. For: May 11 Filed by: Hill Stephen J.

Mon, 15 Jun 2026 18:34:00 -0400
si-local-file:///var/storage/secattach/20260615/26648921.html

Form 4 Lyell Immunopharma, Inc. For: May 11 Filed by: Bulis Veronica Sanchez

Mon, 15 Jun 2026 18:32:00 -0400
si-local-file:///var/storage/secattach/20260615/26648919.html

Form 4 Lyell Immunopharma, Inc. For: May 11 Filed by: Bulis Veronica Sanchez

Mon, 15 Jun 2026 18:32:00 -0400
si-local-file:///var/storage/secattach/20260615/26648919.html

Form 8-K Lyell Immunopharma, Inc. For: Jun 10

Mon, 15 Jun 2026 16:06:00 -0400
si-local-file:///var/storage/secattach/20260615/26647315.html

Form 8-K Lyell Immunopharma, Inc. For: Jun 10

Mon, 15 Jun 2026 16:06:00 -0400
si-local-file:///var/storage/secattach/20260615/26647315.html